Skip to content

Untargeted metabolomic study on the insomnia

Untargeted metabolomics and mechanism exploration of Hunan Chinese insomnia population

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043431
Enrollment
Unknown
Registered
2021-02-17
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

insomnia

Interventions

insomnia patient group vs. normal control group:Nil

Sponsors

The Second Affiliated Hospital, University of South China
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The insomnia patient selection was in accordance with diagnostic criteria from the International Classification of Sleep Disorder, 3rd (ICSD-3). The control group was healthy people. All of them were unrelated Chinese Han population. The informed consent was signed by the patient or his guardian.

Exclusion criteria

Exclusion criteria: All patients received the final diagnosis by the patients clinic, Pittsburgh Sleep Quality Index (PSQI), Self-rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS) and Polysomnography (PSG) results. None of the subjects had pregnancies, chronic pain, malignant tumor, moderate to severe mental disorders, dementia, stroke, obstructive sleep apnea hypopnea syndrome, a history of taking corticosteroids or psychotropic drugs, or a history of major emotional trauma six months before sampling.

Design outcomes

Primary

MeasureTime frame
Metabolites;

Countries

China

Contacts

Public ContactMei Yuan

Department of Neurology, the Second Affiliated Hospital, University of South China

meimeihaijun@163.com+86 18684571188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026